Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients

S. Jean Hsieh, Lorraine B. Ware, Mark D. Eisner, Lisa Yu, Peyton Jacob, Christopher Havel, MacIej L. Goniewicz, Michael A. Matthay, Neal L. Benowitz, Carolyn S. Calfee

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Objectives: The association between tobacco smoke exposure and critical illness is not well studied, largely because obtaining an accurate smoking history from critically ill patients is difficult. Biomarkers can provide quantitative data on active and secondhand cigarette smoke exposure. We sought to compare cigarette smoke exposure as measured by biomarkers to exposure by self-report in a cohort of critically ill patients and to determine how well biomarkers of cigarette smoke exposure correlate with each other in this population. Design, setting, and Patients: Serum and urine cotinine and trans-3′-hydroxycotinine, urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol, and hair and nail nicotine levels were measured in 60 subjects enrolled in an observational cohort of critically ill subjects at a tertiary academic medical center in Tennessee. Smoking history was obtained from patients, their surrogates, or the medical chart. Cigarette smoke exposure as measured by biomarkers was compared to exposure by history. Measurements and main results: By smoking history, 29 subjects were identified as smokers, 28 were identified as nonsmokers, and 3 were identified as unknown. The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol identified 27 of the 28 nonsmokers by history either as active smokers (n = 6, 21%) or as exposed to secondhand smoke (n = 21, 75%). All biomarker levels were strongly correlated with each other (r = .69-.95, p < .0001). Conclusions: The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol identified considerably more active smokers than did smoking history and detected a high prevalence of secondhand smoke exposure in a critically ill population. These markers will be important for future studies investigating the relationship between active smoking and secondhand smoke exposure and critical illness.

Original languageEnglish (US)
Pages (from-to)40-45
Number of pages6
JournalCritical Care Medicine
Volume39
Issue number1
DOIs
StatePublished - Jan 2011
Externally publishedYes

Fingerprint

Tobacco Smoke Pollution
Critical Illness
Biomarkers
Smoking
History
Cotinine
Smoke
Tobacco Products
Urine
Serum
Nails
Nicotine
Hair
Self Report
Population
Tobacco
4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol

Keywords

  • biomarkers
  • cigarette smoking
  • cotinine
  • critically ill
  • NNAL

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Hsieh, S. J., Ware, L. B., Eisner, M. D., Yu, L., Jacob, P., Havel, C., ... Calfee, C. S. (2011). Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. Critical Care Medicine, 39(1), 40-45. https://doi.org/10.1097/CCM.0b013e3181fa4196

Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. / Hsieh, S. Jean; Ware, Lorraine B.; Eisner, Mark D.; Yu, Lisa; Jacob, Peyton; Havel, Christopher; Goniewicz, MacIej L.; Matthay, Michael A.; Benowitz, Neal L.; Calfee, Carolyn S.

In: Critical Care Medicine, Vol. 39, No. 1, 01.2011, p. 40-45.

Research output: Contribution to journalArticle

Hsieh, SJ, Ware, LB, Eisner, MD, Yu, L, Jacob, P, Havel, C, Goniewicz, ML, Matthay, MA, Benowitz, NL & Calfee, CS 2011, 'Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients', Critical Care Medicine, vol. 39, no. 1, pp. 40-45. https://doi.org/10.1097/CCM.0b013e3181fa4196
Hsieh, S. Jean ; Ware, Lorraine B. ; Eisner, Mark D. ; Yu, Lisa ; Jacob, Peyton ; Havel, Christopher ; Goniewicz, MacIej L. ; Matthay, Michael A. ; Benowitz, Neal L. ; Calfee, Carolyn S. / Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients. In: Critical Care Medicine. 2011 ; Vol. 39, No. 1. pp. 40-45.
@article{82faab9f3b2e4f9b96ecc303020cb629,
title = "Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients",
abstract = "Objectives: The association between tobacco smoke exposure and critical illness is not well studied, largely because obtaining an accurate smoking history from critically ill patients is difficult. Biomarkers can provide quantitative data on active and secondhand cigarette smoke exposure. We sought to compare cigarette smoke exposure as measured by biomarkers to exposure by self-report in a cohort of critically ill patients and to determine how well biomarkers of cigarette smoke exposure correlate with each other in this population. Design, setting, and Patients: Serum and urine cotinine and trans-3′-hydroxycotinine, urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol, and hair and nail nicotine levels were measured in 60 subjects enrolled in an observational cohort of critically ill subjects at a tertiary academic medical center in Tennessee. Smoking history was obtained from patients, their surrogates, or the medical chart. Cigarette smoke exposure as measured by biomarkers was compared to exposure by history. Measurements and main results: By smoking history, 29 subjects were identified as smokers, 28 were identified as nonsmokers, and 3 were identified as unknown. The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol identified 27 of the 28 nonsmokers by history either as active smokers (n = 6, 21{\%}) or as exposed to secondhand smoke (n = 21, 75{\%}). All biomarker levels were strongly correlated with each other (r = .69-.95, p < .0001). Conclusions: The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol identified considerably more active smokers than did smoking history and detected a high prevalence of secondhand smoke exposure in a critically ill population. These markers will be important for future studies investigating the relationship between active smoking and secondhand smoke exposure and critical illness.",
keywords = "biomarkers, cigarette smoking, cotinine, critically ill, NNAL",
author = "Hsieh, {S. Jean} and Ware, {Lorraine B.} and Eisner, {Mark D.} and Lisa Yu and Peyton Jacob and Christopher Havel and Goniewicz, {MacIej L.} and Matthay, {Michael A.} and Benowitz, {Neal L.} and Calfee, {Carolyn S.}",
year = "2011",
month = "1",
doi = "10.1097/CCM.0b013e3181fa4196",
language = "English (US)",
volume = "39",
pages = "40--45",
journal = "Critical Care Medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Biomarkers increase detection of active smoking and secondhand smoke exposure in critically ill patients

AU - Hsieh, S. Jean

AU - Ware, Lorraine B.

AU - Eisner, Mark D.

AU - Yu, Lisa

AU - Jacob, Peyton

AU - Havel, Christopher

AU - Goniewicz, MacIej L.

AU - Matthay, Michael A.

AU - Benowitz, Neal L.

AU - Calfee, Carolyn S.

PY - 2011/1

Y1 - 2011/1

N2 - Objectives: The association between tobacco smoke exposure and critical illness is not well studied, largely because obtaining an accurate smoking history from critically ill patients is difficult. Biomarkers can provide quantitative data on active and secondhand cigarette smoke exposure. We sought to compare cigarette smoke exposure as measured by biomarkers to exposure by self-report in a cohort of critically ill patients and to determine how well biomarkers of cigarette smoke exposure correlate with each other in this population. Design, setting, and Patients: Serum and urine cotinine and trans-3′-hydroxycotinine, urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol, and hair and nail nicotine levels were measured in 60 subjects enrolled in an observational cohort of critically ill subjects at a tertiary academic medical center in Tennessee. Smoking history was obtained from patients, their surrogates, or the medical chart. Cigarette smoke exposure as measured by biomarkers was compared to exposure by history. Measurements and main results: By smoking history, 29 subjects were identified as smokers, 28 were identified as nonsmokers, and 3 were identified as unknown. The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol identified 27 of the 28 nonsmokers by history either as active smokers (n = 6, 21%) or as exposed to secondhand smoke (n = 21, 75%). All biomarker levels were strongly correlated with each other (r = .69-.95, p < .0001). Conclusions: The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol identified considerably more active smokers than did smoking history and detected a high prevalence of secondhand smoke exposure in a critically ill population. These markers will be important for future studies investigating the relationship between active smoking and secondhand smoke exposure and critical illness.

AB - Objectives: The association between tobacco smoke exposure and critical illness is not well studied, largely because obtaining an accurate smoking history from critically ill patients is difficult. Biomarkers can provide quantitative data on active and secondhand cigarette smoke exposure. We sought to compare cigarette smoke exposure as measured by biomarkers to exposure by self-report in a cohort of critically ill patients and to determine how well biomarkers of cigarette smoke exposure correlate with each other in this population. Design, setting, and Patients: Serum and urine cotinine and trans-3′-hydroxycotinine, urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol, and hair and nail nicotine levels were measured in 60 subjects enrolled in an observational cohort of critically ill subjects at a tertiary academic medical center in Tennessee. Smoking history was obtained from patients, their surrogates, or the medical chart. Cigarette smoke exposure as measured by biomarkers was compared to exposure by history. Measurements and main results: By smoking history, 29 subjects were identified as smokers, 28 were identified as nonsmokers, and 3 were identified as unknown. The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol identified 27 of the 28 nonsmokers by history either as active smokers (n = 6, 21%) or as exposed to secondhand smoke (n = 21, 75%). All biomarker levels were strongly correlated with each other (r = .69-.95, p < .0001). Conclusions: The combination of serum cotinine and urine 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanol identified considerably more active smokers than did smoking history and detected a high prevalence of secondhand smoke exposure in a critically ill population. These markers will be important for future studies investigating the relationship between active smoking and secondhand smoke exposure and critical illness.

KW - biomarkers

KW - cigarette smoking

KW - cotinine

KW - critically ill

KW - NNAL

UR - http://www.scopus.com/inward/record.url?scp=78651241449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78651241449&partnerID=8YFLogxK

U2 - 10.1097/CCM.0b013e3181fa4196

DO - 10.1097/CCM.0b013e3181fa4196

M3 - Article

C2 - 20935560

AN - SCOPUS:78651241449

VL - 39

SP - 40

EP - 45

JO - Critical Care Medicine

JF - Critical Care Medicine

SN - 0090-3493

IS - 1

ER -